

Christina Hanson, MS, FNP presents: Disease Overview of Nonalcoholic Steatohepatitis (NASH): The Active, Progressive Form of Nonalcoholic Fatty Liver Disease (NAFLD): Definitions and Epidemiology; Pathophysiology; Natural History of the Disease; Morbidity and Mortality
Nov 24, 2022
Christina Hanson, an expert in Nonalcoholic Steatohepatitis (NASH) and Nonalcoholic Fatty Liver Disease (NAFLD), shares her insights on these pressing health issues. She discusses the alarming rise in NAFLD cases linked to obesity and diabetes. Hanson breaks down the differences between NAFLD and its progressive form, NASH, emphasizing the importance of understanding disease progression and epidemiology. She also highlights how fibrosis affects patient outcomes, making this a crucial topic for anyone interested in liver health.
Chapters
Transcript
Episode notes